FDA Drug Application (084735) for APRESAZIDE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number084735
Product Number001
FormCAPSULE;ORAL
Dosage25MG;25MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPRESAZIDE
Active IngredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by NOVARTIS